Phaneendra.K
☆    

2011-05-11 10:56
(5526 d 06:22 ago)

Posting: # 7001
Views: 3,337
 

 BE study for modified release dosage forms [Design Issues]

Hi,
If a drug X of the innovator has got the formulation of immediate release oral tablets, and, a modified release tablet of the same, eg. extended release, has been developed, then how to conduct the BE study. (Will it be acceptible?)
Does it get the generic approval?

Thanks and Regards,

PK
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2011-05-11 13:25
(5526 d 03:53 ago)

@ Phaneendra.K
Posting: # 7005
Views: 2,661
 

 BE study for modified release dosage forms

Dear Phani!

See e.g., Appendix 1 to the EU-GL. Generally you have to perform a clinical study also (Section 4.2).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
353 visitors (0 registered, 353 guests [including 22 identified bots]).
Forum time: 17:18 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5